Comparative effectiveness of dabigatran, rivaroxaban, and edoxaban on cardiac and renal outcomes in Asian patients with atrial fibrillation: a propensity score-weighted analysis
Event:
ESC Congress 2025
Topic:
Oral Anticoagulation
Session:
Drivers and modifiers of atrial fibrillation